<DOC>
	<DOCNO>NCT00370981</DOCNO>
	<brief_summary>The purpose study evaluate pagoclone treatment premature ejaculation .</brief_summary>
	<brief_title>Exploratory Study Pagoclone Men With Premature Ejaculation .</brief_title>
	<detailed_description>The primary objective study evaluate effect 3 dose level pagoclone ( 0.15 mg , 0.30 mg , 0.60 mg ) versus placebo intravaginal ejaculation latency time ( IELT ) male patient primary premature ejaculation .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>A male regularly experience premature ejaculation 18 55 yr old In Stable relationship one woman least 6 month</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>investigational drug</keyword>
	<keyword>ejaculation</keyword>
</DOC>